The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR-TKIs but is not an indication of acquired resistance to EGFR-TKIs in NSCLC patients with EGFR mutationsm
about
The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR-TKIs but is not an indication of acquired resistance to EGFR-TKIs in NSCLC patients with EGFR mutationsm
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The level of serum carcinoembr ...... patients with EGFR mutationsm
@ast
The level of serum carcinoembr ...... patients with EGFR mutationsm
@en
type
label
The level of serum carcinoembr ...... patients with EGFR mutationsm
@ast
The level of serum carcinoembr ...... patients with EGFR mutationsm
@en
prefLabel
The level of serum carcinoembr ...... patients with EGFR mutationsm
@ast
The level of serum carcinoembr ...... patients with EGFR mutationsm
@en
P2093
P2860
P356
P1433
P1476
The level of serum carcinoembr ...... patients with EGFR mutationsm
@en
P2093
Guibin Zhao
Jingquan Han
Shouqiang Cao
Xiangyu Zhang
Yuzhang Li
P2860
P356
10.3892/BR.2017.914
P577
2017-05-19T00:00:00Z